Veeva Approved Email is the pharma standard for compliant, pre-approved messaging. Highp complements—and when needed, substitutes—this channel with direct-to-phone video, MLR-approved SMS/WhatsApp, and interactive personal landing-pages that convert. Together, they deliver higher completion rates, clearer calls-to-action, and faster time-to-impact in HCP engagement.
Approved Email vs. multichannel campaigns—what’s the difference, and how Highp bridges it
Veeva Approved Email excels at compliant, rep-as-sender, on-demand 1:1 outreach using pre-approved fragments and strict personalization controls—ideal for field-led moments. By contrast, many additional campaign tools can orchestrate bulk email/SMS/WhatsApp programs, but typically cannot send “from” the named representative and often lack governed personalization limits (e.g., fragments, versioning, channel-level consent), creating risk or inconsistency.
Highp tackles both approaches simultaneously: it preserves rep identity and guardrails for Approved Email use cases, and empowers marketing to run compliant, large-scale email + approved SMS/WhatsApp campaigns with hyper-personalized video (selfie, screen-share, audio notes), drag-and-drop landing-page widgets, and unified analytics—so field force and marketing work in concert, not in silos.
One platform—no stitching required
With Highp, you don’t need to bolt together separate services for secure mass outreach—email, SMS, and WhatsApp are delivered from a single, compliant platform. Highp handles sender governance, consent and preferences, bounce and number validation (hard/soft email bounces, delivery receipts, and phone health checks), deduplication, throttling/rate-limits, audit logging, and analytics end-to-end. Beyond transport, Highp unifies 20+ critical capabilities—from hyper-personalized video and rep selfie/screen-share, to drag-and-drop landing-page widgets (surveys, webinars, consent), through reporting and CRM sync—so marketing and field can run large-scale campaigns without stitching gateways or add-ons.
Where Highp fits with Veeva Approved Email
- As a companion: Embed Highp links/animated previews inside Veeva Approved Email to drive one-tap, mobile-first viewing and action (samples, rep callback, webinar reg).
- As an alternative when Veeva CRM isn’t deployed: Run compliant campaigns entirely in Highp—production, delivery (email + SMS/WhatsApp), landing-page, consent, and analytics included.
Personalization that goes beyond fragments
Veeva’s reusable fragments (headlines, claims, ISI blocks) enable structured email content. Highp builds on that logic with hyper video personalization:
- Rep-generated media: add a selfie video, screen-share walkthrough, or audio note to a poster or visual.
- Dynamic variants: auto-swap intros, thumbnails, CTAs, or references by specialty, country, or access status.
- Contextual CTAs: tailor actions per account (e.g., “book a call with {{rep.name}},” “request samples,” “join local webinar”).
Result: messages feel human, relevant, and action-oriented—ideal for medically governed brands.
Beyond email: approved SMS & WhatsApp
Some HCPs won’t engage via email alone. Highp adds consent-based, MLR-approved SMS and WhatsApp templates to your mix, keeping all touchpoints auditable:
- Use cases: launch nudges, conference highlights, safety updates, rep follow-ups, pharmacist education.
- Governance: opt-in/out tracking, approved copy blocks, audit logs, and regional policy controls.
Not just a message: an interactive personal landing-page
Every Highp send opens to a personalized landing-page that marketing can assemble—with no IT—via drag-and-drop. Choose from 20+ interactive widgets to turn attention into action.
Each landing-page is unique per message (rep, country, indication), enabling granular analytics and real-time optimization.
Compliance, consent, and auditability
- Pre-approved content paths (email/SMS/WhatsApp) with version control.
- Consent & preferences stored and synced; automated opt-out handling.
- Audit trail across message, landing-page, and CTA events; exportable logs.
- Medical/Promo separation options for MSL vs. sales scenarios.
Analytics that matter to brand and field
Track the full funnel—not just opens: delivery, video starts/completions, CTR/CTOR, widget engagement, meeting-set rate, sample requests, consent growth, and rep-initiated follow-up. Dashboards attribute outcomes by rep, specialty, asset, and channel (Approved Email vs. SMS/WhatsApp), closing the loop with CRM.
Implementation patterns
If you have Veeva CRM
- Keep Veeva Approved Email as your compliant reach channel.
- Add Highp previews/links into templates and fragments.
- Enable reps to append selfie/screen-share content and drive to the interactive landing-page.
- Measure incremental lift vs. email-only journeys.
If you don’t have Veeva CRM
- Run end-to-end in Highp: build copy, video variants, and landing-pages; deliver via email, SMS/WhatsApp; capture consent; analyze and iterate—without IT projects.
When to use Highp + Veeva Approved Email
- Launch waves & NPP: rapid SOV building with KOL video and one-tap CTAs.
- Conference highlights: ASH/ASCO/ACR recaps delivered the day sessions end.
- Safety & access updates: short explainers with embedded confirmation.
- Rep follow-ups: personal video notes boost response and meeting-set rate.
- Pharmacist education: micro-learning with quizzes and certificates.
KPIs & success criteria
- Video completion rate (VCR) on mobile
- CTOR across Approved Email vs. SMS/WhatsApp cohorts
- CTA conversion (meetings, samples, webinar regs)
- New consents/preferences captured
- Time-to-first-view and repeat engagement
- Brand SOV and account-level coverage
Why teams choose Highp
- Speed: drag-and-drop build; go live in days, not quarters.
Contact.needtoreach
Contact.freeconsultation
Contact.consultationdescription